Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Oculomics in Bipolar Affective Disorder: Insights from Retinal Imaging
Author Affiliations & Notes
  • Ines Drira
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Ana P. Ribeiro Reis
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Siegfried Wagner
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Robbert Struyven
    University College London, London, United Kingdom
  • Dominic Williamson
    University College London, London, United Kingdom
  • Mark Chia
    University College London, London, United Kingdom
  • Yukun Zhou
    University College London, London, United Kingdom
  • Timing Liu
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Anthony P Khawaja
    University College London, London, United Kingdom
  • Axel Petzold
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Steven Silverstein
    University of Rochester Medical Center, Rochester, New York, United States
  • Praveen J Patel
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Nikolas Pontikos
    University College London, London, United Kingdom
  • Konstantinos Balaskas
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Pearse Andrew Keane
    Moorfields Eye Hospital NHS Foundation Trust, London, London, United Kingdom
  • Footnotes
    Commercial Relationships   Ines Drira None; Ana P. Ribeiro Reis None; Siegfried Wagner None; Robbert Struyven None; Dominic Williamson None; Mark Chia None; Yukun Zhou None; Timing Liu None; Anthony Khawaja Abbvie,Aerie,Google Health,Novartis,Reichart,Santen,Thea, Code C (Consultant/Contractor); Axel Petzold NIHR BRC,Novartis,Heidelberg, Code C (Consultant/Contractor); Steven Silverstein None; Praveen Patel Bayer,Roche, Code C (Consultant/Contractor); Nikolas Pontikos None; Konstantinos Balaskas None; Pearse Keane AbbVie,Google Health,Roche,Apellis, Novartis,RetinAI,Bitfound, Code C (Consultant/Contractor), Bayer, Code S (non-remunerative)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1507. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ines Drira, Ana P. Ribeiro Reis, Siegfried Wagner, Robbert Struyven, Dominic Williamson, Mark Chia, Yukun Zhou, Timing Liu, Anthony P Khawaja, Axel Petzold, Steven Silverstein, Praveen J Patel, Nikolas Pontikos, Konstantinos Balaskas, Pearse Andrew Keane; Oculomics in Bipolar Affective Disorder: Insights from Retinal Imaging. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1507.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Neuroimaging and optical coherence tomography (OCT) studies in bipolar affective disorder (BPAD) indicate neurodegenerative changes in cortical matter and reduced thickness in the retinal nerve fibre layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL). In this study, we explored associations between BPAD and inner retinal thickness using OCT and color fundus photography (CFP) in a real-world cohort to gain insights into the neurobiology of BPAD.

Methods : The dataset originated from the retrospective AlzEye cohort, comprising 154,830 patients aged 40 years and older at Moorfields Eye Hospital, from January 2008 to April 2018. OCT and CFP were conducted as part of the clinical routine. Ophthalmic data were linked with the Hospital Episode Statistics database for systemic disease data. Macular RNFL, GC-IPL, and Inner Nuclear Layer (INL) thicknesses (μm) were extracted from OCT imaging using a retinal boundary software. Cup-to-Disc Ratio (CDR) was computed from CFP using AutoMorph, a deep learning-based tool. Linear mixed-effects models were employed to investigate the association between BPAD and retinal biomarkers, with exclusions for dementia and adjustments for demographic and systemic confounders.

Results :
209 individuals with BPAD and 96,793 controls (163,686 eyes) met our quality filters and exclusion criteria. BPAD individuals averaged 63 years old (SD±12), 65 years old (SD±14) for controls, with respectively 63% and 52% women. Individuals with BPAD were more likely to have HTN (82%vs48%) and DM (65%vs29%); p=0.001. After adjusting for age, sex, deprivation and ethnicity, the BPAD group had a thinner macular GC-IPL (-1.80μm; 95%CI:-3.50,-0.04; p=0.04), particularly in the subgroup below 55 years old (-3.94μm; 95%CI:-7.17,-0.91; p=0.01). Significance waned when considering HTN and DM (-0.81; 95%CI: -2.41,1.04; p=0.35) and in the older subgroup (-1.64, 95%CI: -3.50;0.25, p=0.08). RNFL was not significantly different. On CFP, younger subgroup CDR was higher (0.02; 95%CI:0.00,0.04; p=0.04).

Conclusions : We report a significant reduction in macular GC-IPL thickness in BPAD patients, especially those below 55 years old, accompanied by a larger cup-to-disc ratio (CDR). Although the adjustment of DM and HTN attenuated the strength of the association, these findings suggest an increased prevalence of cardiovascular risk factors that contribute to neurodegeneration in individuals with BPAD, in an ophthalmic cohort.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×